Skip to Main Content (Press Enter)

Logo UNIMI
  • ×
  • Home
  • Persone
  • Attività
  • Ambiti
  • Strutture
  • Pubblicazioni
  • Terza Missione

Expertise & Skills
Logo UNIMI

|

Expertise & Skills

unimi.it
  • ×
  • Home
  • Persone
  • Attività
  • Ambiti
  • Strutture
  • Pubblicazioni
  • Terza Missione
  1. Home

Consensus Statement on the definition and classification of metabolic hyperferritinaemia

Articolo
Data di Pubblicazione:
2023
Citazione:
Consensus Statement on the definition and classification of metabolic hyperferritinaemia / L. Valenti, E. Corradini, L.A. Adams, E. Aigner, S. Alqahtani, M. Arrese, E. Bardou-Jacquet, E. Bugianesi, J. Fernandez-Real, D. Girelli, H. Hagström, B. Henninger, K. Kowdley, G. Ligabue, D. Mcclain, F. Lainé, K. Miyanishi, M.U. Muckenthaler, A. Pagani, P. Pedrotti, A. Pietrangelo, D. Prati, J.D. Ryan, L. Silvestri, C.W. Spearman, P. Stål, E.A. Tsochatzis, F. Vinchi, M. Zheng, H. Zoller. - In: NATURE REVIEWS. ENDOCRINOLOGY. - ISSN 1759-5029. - 19:5(2023 May), pp. 299-310. [10.1038/s41574-023-00807-6]
Abstract:
Hyperferritinaemia is a common laboratory finding that is often associated with metabolic dysfunction and fatty liver. Metabolic hyperferritinaemia reflects alterations in iron metabolism that facilitate iron accumulation in the body and is associated with an increased risk of cardiometabolic and liver diseases. Genetic variants that modulate iron homeostasis and tissue levels of iron are the main determinants of serum levels of ferritin in individuals with metabolic dysfunction, raising the hypothesis that iron accumulation might be implicated in the pathogenesis of insulin resistance and the related organ damage. However, validated criteria for the non-invasive diagnosis of metabolic hyperferritinaemia and the staging of iron overload are still lacking, and there is no clear evidence of a benefit for iron depletion therapy. Here, we provide an overview of the literature on the relationship between hyperferritinaemia and iron accumulation in individuals with metabolic dysfunction, and on the associated clinical outcomes. We propose an updated definition and a provisional staging system for metabolic hyperferritinaemia, which has been agreed on by a multidisciplinary global panel of expert researchers. The goal is to foster studies into the epidemiology, genetics, pathophysiology, clinical relevance and treatment of metabolic hyperferritinaemia, for which we provide suggestions on the main unmet needs, optimal design and clinically relevant outcomes.This Consensus Statement discusses the relationship between hyperferritinaemia and iron accumulation in individuals with metabolic dysfunction. The authors propose an updated definition and a provisional staging system for metabolic hyperferritinaemia, highlight research gaps and provide suggestions for the design and outcome measures for future studies.
Tipologia IRIS:
01 - Articolo su periodico
Elenco autori:
L. Valenti, E. Corradini, L.A. Adams, E. Aigner, S. Alqahtani, M. Arrese, E. Bardou-Jacquet, E. Bugianesi, J. Fernandez-Real, D. Girelli, H. Hagström, B. Henninger, K. Kowdley, G. Ligabue, D. Mcclain, F. Lainé, K. Miyanishi, M.U. Muckenthaler, A. Pagani, P. Pedrotti, A. Pietrangelo, D. Prati, J.D. Ryan, L. Silvestri, C.W. Spearman, P. Stål, E.A. Tsochatzis, F. Vinchi, M. Zheng, H. Zoller
Autori di Ateneo:
VALENTI LUCA VITTORIO CARLO ( autore )
Link alla scheda completa:
https://air.unimi.it/handle/2434/975496
Progetto:
Liver Investigation: Testing Marker Utility in Steatohepatitis
  • Aree Di Ricerca

Aree Di Ricerca

Settori


Settore MED/09 - Medicina Interna
  • Informazioni
  • Assistenza
  • Accessibilità
  • Privacy
  • Utilizzo dei cookie
  • Note legali

Realizzato con VIVO | Progettato da Cineca | 24.12.0.7